Cisatracurium besylate is a potent, non-depolarizing neuromuscular blocking agent belonging to the benzylisoquinoline class. Used primarily as a muscle relaxant during surgical anesthesia and in intensive… Read more





























Cisatracurium besylate is a potent, non-depolarizing neuromuscular blocking agent belonging to the benzylisoquinoline class. Used primarily as a muscle relaxant during surgical anesthesia and in intensive care settings, it functions by competitively inhibiting acetylcholine receptors at the neuromuscular junction to prevent nerve-to-muscle signal transmission. To support accurate pharmaceutical analysis, this category features essential reference standards, including the active pharmaceutical ingredient, its pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds. Laboratories utilize these high-quality materials for critical analytical testing, such as impurity profiling, the validation of analytical methods, and routine quality control of the parent drug. These compounds enable researchers to precisely identify, characterize, and quantify degradation products or process-related impurities, ensuring consistent efficacy and regulatory compliance throughout the drug development and manufacturing lifecycle.